Corporate GovernanceJul 17, 2026, 04:37 PM
Tempest Therapeutics to Vote on Corporate Governance Amendments
AI Summary
Tempest Therapeutics, Inc. will hold a Special Meeting of Stockholders on July 27, 2026, to vote on amendments to its Restated Certificate of Incorporation. The proposed changes include eliminating restrictions on stockholder action by written consent, requiring approval by a majority of outstanding shares, and replacing supermajority voting requirements with majority-of-outstanding voting standards. The Board of Directors unanimously recommends approval, stating these changes will modernize and simplify governance practices.
Key Highlights
- Special Meeting of Stockholders scheduled for July 27, 2026.
- Proposal 1 seeks to amend the Restated Certificate of Incorporation.
- Changes include permitting stockholder action by written consent with majority approval.
- Supermajority voting requirements will be replaced with majority-of-outstanding standards.
- Approval of Proposal 1 requires 75% of votes entitled to cast in director elections.
- Record date for voting is May 28, 2026, with 14,806,997 shares outstanding.
- The Board of Directors unanimously recommends voting "For" Proposal 1.
Price Impact
More from TPST